# Junta clínica — PT-pseudo_dd011d696387 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_dd011d696387",
  "pid": "PT-pseudo_dd011d696387",
  "task": 1,
  "psa": 10.0,
  "age": 75,
  "months": 3,
  "pirads": "5",
  "psad": 0.372,
  "psav": 0.55,
  "psap": 14.0,
  "vol": 26.91,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.8577571,
  "medhx": "Coronary artery disease, Benign prostatic hyperplasia",
  "meds": "atorvastatin, tamsulosin",
  "notes": "PSA 10 ng/mL. PI-RADS 5. PSAD 0.37. Prostate volume 27 mL. csPCa 0.86.",
  "pmhx": [
    "Coronary artery disease",
    "Benign prostatic hyperplasia"
  ],
  "allergies": [],
  "vitals": {
    "weight": "92 kg",
    "height": "179 cm",
    "bmi": "28.7",
    "bp": "101/75 mmHg",
    "hr": "73 bpm",
    "smoking": "Ex-smoker (13 pack-yr, quit 2002)",
    "last_dental": "6 mo ago",
    "flu_vax": "Sep 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "11 Jan 2025",
  "enc_ref": "Dr. M. Jansen (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical attention sought for reassessment of a previously confirmed prostate malignancy alongside recent fluctuations in prostate-specific antigen levels."
    },
    {
      "s": "History",
      "t": "Clinical review initiated to reassess a previously established prostate cancer diagnosis. At 75 years of age, he works as an active dairy farmer and resides independently as a widower, relying on his adult daughter as his main point of contact. Body mass indexes 28.7 at a weight of 92 kg. Tobacco use ceased in 2002, accounting for a cumulative 13 pack-year exposure. Chronic coronary artery disease remains controlled via atorvastatin, while tamsulosin addresses benign prostatic hyperplasia; lower urinary tract symptoms are negligible, scoring just 2 on the IPSS scale. Daily life centers around agricultural work, with otherwise limited physical activity. Alcohol intake stays around three units weekly. Public transit limitations dictate a preference for morning visits. A decades-old meniscal injury occasionally flares during wet conditions, and he maintains routine cardiology appointments solely for blood pressure tracking. Unexplained weight reduction, skeletal discomfort, and blood in the urine are firmly denied, as he prioritizes continuing his agricultural schedule. December 2024 bloodwork revealed a prostate-specific antigen level of 10.0 ng/mL (free fraction 16%), complemented by unremarkable renal panels and complete blood counts. No medication sensitivities exist."
    },
    {
      "s": "Physical examination",
      "t": "Digital rectal examination proves normal; the prostate presents as symmetrically enlarged with a smooth, firm consistency and absent nodules or asymmetry. Hemodynamic parameters show a blood pressure of 101/75 mmHg and a pulse of 73 beats per minute. Systemic assessment identifies a well-nourished individual exhibiting no signs of acute distress; pulmonary fields are clear and cardiac rhythm remains regular."
    }
  ],
  "occupation": "active dairy farmer",
  "marital": "Widowed",
  "living": "Lives alone; adult daughter is primary contact",
  "next_of_kin": "None recorded — patient declines to nominate",
  "recent_other": [],
  "alcohol": "3 units / week",
  "exercise": "Sedentary lifestyle, occasional walking",
  "ipss": "IPSS score: 2/35 (mild LUTS)",
  "admin": "Patient prefers morning appointments (public transport).",
  "mri_hospital": "UMCG (Groningen)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_dd011d696387
Task: 1

Encounter: Urology - outpatient on 11 Jan 2025.
Referrer: Dr. M. Jansen (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 75-year-old male
  - PSA: 10.0 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.372 ng/mL²
  - PSA velocity: 0.55 ng/mL/yr
  - Prior PSA: 14.0 ng/mL
  - Prostate volume: 26.91 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.8577571 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Coronary artery disease, Benign prostatic hyperplasia
  - Problem list / PMHx: Coronary artery disease, Benign prostatic hyperplasia
  - Current medication: atorvastatin, tamsulosin
  - Allergies: NKA
  - Additional notes: PSA 10 ng/mL. PI-RADS 5. PSAD 0.37. Prostate volume 27 mL. csPCa 0.86.

Vitals: weight 92 kg, height 179 cm, BMI 28.7, BP 101/75 mmHg, HR 73 bpm. Smoking: Ex-smoker (13 pack-yr, quit 2002).

Chief complaint: Clinical attention sought for reassessment of a previously confirmed prostate malignancy alongside recent fluctuations in prostate-specific antigen levels.

History: Clinical review initiated to reassess a previously established prostate cancer diagnosis. At 75 years of age, he works as an active dairy farmer and resides independently as a widower, relying on his adult daughter as his main point of contact. Body mass indexes 28.7 at a weight of 92 kg. Tobacco use ceased in 2002, accounting for a cumulative 13 pack-year exposure. Chronic coronary artery disease remains controlled via atorvastatin, while tamsulosin addresses benign prostatic hyperplasia; lower urinary tract symptoms are negligible, scoring just 2 on the IPSS scale. Daily life centers around agricultural work, with otherwise limited physical activity. Alcohol intake stays around three units weekly. Public transit limitations dictate a preference for morning visits. A decades-old meniscal injury occasionally flares during wet conditions, and he maintains routine cardiology appointments solely for blood pressure tracking. Unexplained weight reduction, skeletal discomfort, and blood in the urine are firmly denied, as he prioritizes continuing his agricultural schedule. December 2024 bloodwork revealed a prostate-specific antigen level of 10.0 ng/mL (free fraction 16%), complemented by unremarkable renal panels and complete blood counts. No medication sensitivities exist.

Physical examination: Digital rectal examination proves normal; the prostate presents as symmetrically enlarged with a smooth, firm consistency and absent nodules or asymmetry. Hemodynamic parameters show a blood pressure of 101/75 mmHg and a pulse of 73 beats per minute. Systemic assessment identifies a well-nourished individual exhibiting no signs of acute distress; pulmonary fields are clear and cardiac rhythm remains regular.

Patient info: active dairy farmer; Widowed; Lives alone; adult daughter is primary contact.
Next of kin: None recorded — patient declines to nominate.

Lifestyle: alcohol 3 units / week; exercise Sedentary lifestyle, occasional walking; IPSS score: 2/35 (mild LUTS).


Admin: Patient prefers morning appointments (public transport).

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.75
  uncertainty  +/- 0.15 epistemic (95% band 0.45-1.00); among patients I cannot tell apart the outcome was 0.82 of 1.00 mixed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 60% of the time over the 20 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 2 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 75 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 10 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 26.91 mL (1% of my signal; from log_vol, vol) · PSA density = 0.372 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.86 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 60% of the time over the 20 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 75 · DRE = Normal · PSA = 10 ng/mL · prostate volume = 26.91 mL · PSA density = 0.372 · PI-RADS = 5 · comorbidity = 2 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 48 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.63: PI-RADS 5, PSA 10.0, PSAD 0.27, age 75, DRE Normal -> BIOPSY (clear). He wrote: "New(? -> no old MRI report included) PIRADS 5 and rising PSA makes biopsy necessary"
  2. distance 0.79: PI-RADS 5, PSA 9.3, PSAD 0.516, age 71, DRE Normal -> DEFER (clear). He wrote: "He has a ISUP3 cancer diagnosis already and he should be recommended treatment"
  3. distance 1.35: PI-RADS 5, PSA 13.5, PSAD 0.452, age 66, DRE Normal -> BIOPSY (clear). He wrote: "PIRADS 5 lesion in a man in active surveillance."

PRECEDENT: BIOPSY (weighted vote 0.65 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 5
  important  prior biopsy = Positive · age = 75 · PSA density = 0.372
  noted      family history = not opened (0 of 91) · DRE = Normal · PSA = 10 ng/mL · prostate volume = 26.91 mL · comorbidity = 2 on the problem list
  not used   csPCa probability
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 48 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   PI-RADS = 5
  important  prior biopsy = Positive · age = 75 · PSA = 10 ng/mL
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 26.91 mL · PSA density = 0.372 · comorbidity = 2 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
"linking PI-RADS score (1-2, 3, and 4-5) to PSA-D categories (< 0.10, 0.10-0.15, 0.15-0.20 and > 0.20ng/mL) (Table 5.5) [230]. This risk-adapted matrix table may guide the decision to perform a biopsy."
The guideline suggests using a risk-adapted matrix table based on PI-RADS score and PSA density to guide the decision to perform a biopsy. For this patient, the PI-RADS score is 5 and the PSA density is 0.372 ng/mL², which falls into the highest risk category according to the retrieved data.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your bid of BIOPSY p(biopsy) = 0.75 is high, but the guideline treats the PI-RADS score and PSA density as key determinants. The guideline suggests that a low-risk profile (e.g., PI-RADS 1-3 and PSA-D < 0.15ng/mL/cc) could allow for biopsy avoidance. The guideline requires the prior grade of the prior biopsy to be established to determine the next step, which is a fact the panel does not represent.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the trend of the PSA: the

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case hinges entirely on the documented grade of the prior biopsy and the surveillance plan detailed in the previous notes.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Whether the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> The trend of the PSA.
  previous_notes (get_previous_notes) -> The documented grade of the prior biopsy and surveillance protocol status.
  laboratory_results (get_lab_results) -> The full panel results, specifically the DRE finding.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?
  Q2. Is the lesion described in the radiology_report compared against an earlier study?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
COMPARISON: new
LESION: size and zone of the index lesion, as the report words it: "PI-RADS 5 lesion in the left peripheral zone measuring approximately 14 mm."

psa_trend
The trend of the PSA: PSA 2.9 (Nov 2023) rising to 10.0 (Jan 2025), steepest in the last year.

previous_notes
PRIOR GRADE: not recorded
BIOPSY SESSIONS: 2, on 21 Jul 2023
SURVEILLANCE: Urology consultation arranged to investigate the ongoing marker elevation alongside earlier positive biopsy results.
TREATMENT: none recorded

laboratory_results
DRE finding: "Digital rectal examination proves normal; the prostate presents as symmetrically enlarged with a smooth, firm consistency and absent nodules or asymmetry."

WHAT I DID NOT OPEN
family-history anamnesis, because the prior notes already addressed the relevant history regarding the prior biopsy status.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 5 and PSA density 0.372 ng/mL² fall into the highest risk category according to the EAU guideline.
PSA trend shows a significant rise from 2.9 ng/mL to 10.0 ng/mL over the period.

AGAINST sampling this patient now
Prior biopsy status is not documented in the opened notes, which is a critical missing piece for the decision.

WHERE THIS LEANS
LEAN: unclear

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 10.00 ng/mL over 5 points spanning 14 months; velocity +7.47 ng/mL per year; doubling time about 6 months.
PROJECTION at 6 months: 15.4 ng/mL, conformal 95% band 4.4-53.7.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 10 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.75
  uncertainty  +/- 0.15 epistemic (95% band 0.45-1.00), of which 0.00 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Normal (5% of my signal; from dre_suspicious) · PSA = 10 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 26.91 mL (4% of my signal; from log_vol, vol) · PSA density = 0.372 (0% of my signal; from psad_calc) · comorbidity = 2 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.75  ('supports' tier; weight 2.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.75  ('supports' tier, fusion_full; weight 3.0)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.65  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.75 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('supports' tier, fusion_full). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          75                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:not cohort:not library:not E2:—            -> noted
  psa          10 ng/mL                     E1:not E3:not cohort:not library:not E2:not          -> important
  vol          26.91 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.372                        E1:not E3:not cohort:not library:IMP E2:—            -> noted
  cspca        0.86                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:DEC E2:—            -> decisive
  comorbidity  2 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes, laboratory_results) address the moderator's questions. The `previous_notes` explicitly state "PRIOR GRADE: not recorded," and the `radiology_report` states "COMPARISON: new," directly answering Q1 and Q2.

ALIGNMENT WITH THE PANEL
The retrieved evidence, specifically the lack of a documented prior grade in the notes, aligns with the PANEL-PROTOCOL's finding that "documented prior grade in the opened documents: none recorded," which led to the weighted vote of BIOPSY.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? Answered by the `previous_notes`: "PRIOR GRADE: not recorded."
Q2. Is the lesion described in the radiology_report compared against an earlier study? Answered by the `radiology_report`: "COMPARISON: new."

WHAT CARRIES WEIGHT, AND WHY
<prior biopsy>: not_used / not recorded, because the `previous_notes` explicitly state "PRIOR GRADE: not recorded," which is the critical missing piece the panel noted. I would move this to 'decisive' because the absence of this information directly prevents a definitive decision based on established protocols.
<psa>: important / 10 ng/mL, because the PSA level is noted as important by the panel, and the Expert-PSA noted a rising trajectory.
<pirads>: decisive / 5, because the PI-RADS score of 5 is marked as decisive by the panel, and the EAU guideline suggests this high-risk profile warrants consideration.
My confidence in the record as it stands is borderline, due to the critical missing piece of the prior biopsy grade.

MY SUGGESTION TO THE CHAIR
The panel's decision to BIOPSY is supported by the high-risk imaging (PI-RADS 5) and rising PSA trend, but the decision is not fully settled because the documented prior biopsy grade is missing. I suggest proceeding with BIOPSY, but with the caveat that the final decision hinges on the clinical context surrounding the unrecorded prior biopsy result.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

75 y/o male, PSA 10.0, PI-RADS 5, prior positive biopsy with unrecorded grade. High PI-RADS 5 and rising PSA drive sampling despite prior pathology. Initial ISUP grade not recorded, necessitating biopsy to determine management.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
